Medicaments for the region of the oral cavity

Details Medicaments for the region of the oral cavity Medicaments for the region of the oral cavity

1988-07-22

1991-01-01

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic nonactive ingredient containing other...

Peptide containing

424 80, 424 81, 424435, 424 49, 560 47, 514536, 514944, 514950, 514900, 514901, 514902, 514969, 514777, 514779, 514781, 514782, 514784, A61K 9107, A61K 31195

Patent

active

049818759

ABSTRACT:
Etofenamate is used for the preparation of compositions useful in the treatment of bacterial, viral or fungicidal inflammations in the region of the oral cavity.

REFERENCES:
patent: 4623346 (1986-11-01), von Bittera et al.
patent: 4627852 (1986-12-01), von Bittera et al.
patent: 4746675 (1988-05-01), Makino et al.
patent: 4772470 (1988-09-01), Inoue et al.
patent: 4789667 (1988-12-01), Makino et al.
patent: 4871767 (1989-10-01), Beckermann et al.
The Merck Index, Tenth Edition, Published by Merck & Co., Inc., Rahway, N.J., 1983, p. 559, item 3824.
Chemical Abstracts, Band 76, Nr. 1, 3, Jan. 1972, Seite 31, Zusammenfassung Nr. 277q, Columbus, Ohio, U.S.; A. D. Inglot et al.
"Topical Treatment of Cutaneous Herpes Simplex in Humans with the Non--Steroid Antiinflammatory Drugs Mefenamic Acid and Indomethacim in Demethylsulfoxide", & Arch. Immunol. Ther. Exp., 1971 19 (4), 555-66, *Zusammenfassung, ins bensondere Formel I*.

Affiliated with

Also associated with

Rating

Medicaments for the region of the oral cavity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicaments for the region of the oral cavity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments for the region of the oral cavity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1996565